1387. Phase I Study to Evaluate the Safety and Pharmacokinetics (PK) of Single and Multiple Ascending Doses (SAD/MAD) of Intravenous (IV) Minocycline in Healthy Adult Subjects

BACKGROUND: Carbapenem-resistant Acinetobacter baumannii infections are defined by the WHO as a critical threat. IV minocycline is approved in the United States for treatment of Acinetobacter infections at doses up to 200 mg BID. This study investigated safety and PK of single and multiple doses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornely, Oliver A, Arenz, Dorothee, Barraud, Olivier, Bayliss, Mark, Dimitriou, Vassiliki, Hamacher, Stefanie, Lovering, Andrew M, MacGowan, Alasdair, Cammarata, Sue K, Fusaro, Karen, Griffith, David C, Morgan, Elizabeth, Loutit, Jeffery S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252552/
http://dx.doi.org/10.1093/ofid/ofy210.1218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252552/
http://dx.doi.org/10.1093/ofid/ofy210.1218

Ejemplares similares